Xilio Therapeutics (XLO) Insider Trading
Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Xilio Therapeutics.
Bought (12 mo)
$2,025,620
Sold (12 mo)
$5,696
Insiders Buying (12 mo)
2
Insiders Selling (12 mo)
2
Form 4 Filings (All Time)
90
Most Recent Purchase
March 30, 2026
James Samuel Shannon
Director
$43,950
Most Recent Sale
January 5, 2026
Christopher James Frankenfield
CFO
$4,522
Buys (90d)
0
Sells (90d)
0
Recent Insider Transactions
| Filed | Insider | Role | Type | Value | % Change |
|---|---|---|---|---|---|
| 2026-10-02 | Houvras Yariv | Officer | Award | — | — |
Sign up free to view more insider trades.